Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways

Journal of Neuroscience Research

Volumn 88, Issue 12, 2010, Pages 2569-2577

  Lin, Wensheng ^a,b   Lin, Yifeng ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine; Multiple sclerosis; Myelin; Oligodendrocyte; Signal transduction

Indexed keywords

CYTOKINE; GAMMA INTERFERON; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; INFLAMMATION; MOUSE; MYELIN SHEATH; MYELINATION; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DEMYELINATING AUTOIMMUNE DISEASES, CNS; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NEURAL INHIBITION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 77955477978     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22425     Document Type: Article

References (51)

1. Agresti C, Bernardo A, Del Russo N, Marziali G, Battistini A, Aloisi F, Levi G, Coccia EM. 1998. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes. Eur J Neurosci 10:2975-2983.
2. Alsayed Y, Uddin S, Ahmad S, Majchrzak B, Druker BJ, Fish EN, Platanias LC. 2000. IFN-gamma activates the C3G/Rap1 signaling pathway. J Immunol 164:1800-1806. (Pubitemid 30108732)
3. Balabanov R, Strand K, Kemper A, Lee JY, Popko B. 2006. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma. J Neurosci 26:5143-5152.
4. Bettelli E, Sullivan B, Szabo SJ, Sobel RA, Glimcher LH, Kuchroo VK. 2004. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 200:79-87.
5. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu Rev Immunol 15:749-795.
6. Boyce M, Yuan J. 2006. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13:363-373.
7. Brück W, Kuhlmann T, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206:181-185.
8. Buntinx M, Stinissen P, Steels P, Ameloot M, Raus J. 2002. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. Crit Rev Immunol 22:391-424. (Pubitemid 36548951)
9. Chang YJ, Holtzman MJ, Chen CC. 2002. Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion. Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway. J Biol Chem 277:7118-7126.
10. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. 1996. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7:354-370.
11. Emery B, Butzkueven H, Snell C, Binder M, Kilpatrick TJ. 2006. Oligodendrocytes exhibit selective expression of suppressor of cytokine signaling genes and signal transducer and activator of transcription 1 independent inhibition of interferon-gamma-induced toxicity in response to leukemia inhibitory factor. Neuroscience 137:463-472.
12. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5-7.
13. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
14. Frohman EM, Racke MK, Raine CS. 2006. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 354:942-955.
15. Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, Franciotta DM, Penna G, Comi G, Adorini L, Martino G. 2001. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronicprogressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol 167:1821-1829. (Pubitemid 32703187)
16. Glezer I, Simard AR, Rivest S. 2007. Neuroprotective role of the innate immune system by microglia. Neuroscience 147:867-883.
17. Goto J, Tezuka T, Nakazawa T, Sagara H, Yamamoto T. 2008. Loss of Fyn tyrosine kinase on the C57BL/6 genetic background causes hydrocephalus with defects in oligodendrocyte development. Mol Cell Neurosci 38:203-212.
18. Gough DJ, Levy DE, Johnstone RW, Clarke CJ. 2008. IFNgamma signaling - does it mean JAK-STAT? Cytokine Growth Factor Rev 19:383-394.
19. Gysemans C, Callewaert H, Overbergh L, Mathieu C. 2008. Cytokine signalling in the beta-cell: a dual role for IFNgamma. Biochem Soc Trans 36:328-333. (Pubitemid 351839325)
20. Imitola J, Chitnis T, Khoury SJ. 2005. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 106:163-177.
21. LaFerla FM, Sugarman MC, Lane TE, Leissring MA. 2000. Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J Mol Neurosci 15:45-59. (Pubitemid 32104604)
22. Laursen LS, Chan CW, ffrench-Constant C. 2009. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci 29:9174-9185.
23. Lees JR, Cross AH. 2007. A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J Clin Invest 117:297-299.
24. Lin W, Popko B. 2009. Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci 12:379-385.
25. Lin W, Kemper A, McCarthy KD, Pytel P, Wang JP, Campbell IL, Utset MF, Popko B. 2004. Interferon-gamma induced medulloblastoma in the developing cerebellum. J Neurosci 24:10074-10083.
26. Lin W, Harding HP, Ron D, Popko B. 2005. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol 169:603-612. (Pubitemid 41002853)
27. Lin W, Kemper A, Dupree JL, Harding HP, Ron D, Popko B. 2006. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129:1306-1318.
28. Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, Popko B. 2007. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 117:448-456.
29. Lin W, Kunkler PE, Harding HP, Ron D, Kraig RP, Popko B. 2008. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol 173:1508-1517.
30. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
31. Nguyen H, Ramana CV, Bayes J, Stark GR. 2001. Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem 276:33361-33368. (Pubitemid 37384543)
32. Panitch HS, Hirsch RL, Schindler J, Johnson KP. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097-1102.
33. Popko B, Corbin JG, Baerwald KD, Dupree J, Garcia AM. 1997. The effects of interferon-gamma on the central nervous system. Mol Neurobiol 14:19-35. (Pubitemid 127720195)
34. Qing Y, Stark GR. 2004. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279:41679-41685.
35. Ramana CV, Gil MP, Schreiber RD, Stark GR. 2002. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23:96-101.
36. Renno T, Taupin V, Bourbonnière L, Verge G, Tran E, De Simone R, Krakowski M, Rodriguez M, Peterson A, Owens T. 1998. Interferongamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci 12:376-389.
37. Ron D, Walter P. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529. (Pubitemid 46985379)
38. Rutkowski DT, Kaufman RJ. 2004. A trip to the ER: coping with stress. Trends Cell Biol 14:20-28.
39. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163-189.
40. Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E. 2005. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 175:3946-3954.
41. Skurkovich S, Boiko A, Beliaeva I, Buglak A, Alekseeva T, Smirnova N, Kulakova O, Tchechonin V, Gurova O, Deomina T, Favorova OO, Skurkovic B, Gusev E. 2001. Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosis. Mult Scler 7:277-284.
42. Sperber BR, Boyle-Walsh EA, Engleka MJ, Gadue P, Peterson AC, Stein PL, Scherer SS, McMorris FA. 2001. A unique role for Fyn in CNS myelination. J Neurosci 21:2039-2047. (Pubitemid 32221386)
43. Sredni-Kenigsbuch D. 2002. TH1/TH2 cytokines in the central nervous system. Int J Neurosci 112:665-703.
44. Steinman L. 2001. Blockade of gamma interferon might be beneficial in MS. Mult Scler 7:275-276.
45. Sun D, Ding A. 2006. MyD88-mediated stabilization of interferon-gamma- induced cytokine and chemokine mRNA. Nat Immunol 7:375-381.
46. Sun D, Newman TA, Perry VH, Weller RO. 2004. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis. Neuropathol Appl Neurobiol 30:374-384. (Pubitemid 39120299)
47. Uddin S, Sher DA, Alsayed Y, Pons S, Colamonici OR, Fish EN, White MF, Platanias LC. 1997. Interaction of p59fyn with interferon-activated Jak kinases. Biochem Biophys Res Commun 235:83-88.
48. Wang J, Lin W, Popko B, Campbell I L. 2004. Inducible production of interferon-gamma in the developing brain causes cerebellar dysplasia with activation of the Sonic hedgehog pathway. Mol Cell Neurosci 27:489-496.
49. Wang Y, Ren Z, Tao D, Tilwalli S, Goswami R, Balabanov R. 2010. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells. Glia 58:195-208.
50. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157:3223-3227. (Pubitemid 126449130)
51. Zawadzka M, Franklin RJ. 2007. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology. Curr Opin Neurol 20:294-298.